SPONSOR
Pravat Mandal
Total Trials
2
Recruiting
2
Phases
Phase 1
Pravat Mandal is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Mild Cognitive Impairment (MCI), Parkinsons Disease (PD).
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Pravat Mandal
How many clinical trials has Pravat Mandal sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Pravat Mandal, of which 2 are actively recruiting participants. These trials cover conditions including Mild Cognitive Impairment (MCI), Parkinsons Disease (PD). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Pravat Mandal research focus on?
Pravat Mandal clinical trials span Mild Cognitive Impairment (MCI), Parkinsons Disease (PD). The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Pravat Mandal clinical trial?
To participate in a Pravat Mandal trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Pravat Mandal trials with current recruitment status updated daily.
Clinical Trials by Pravat Mandal
NCT07583251 Phase 1
Recruiting
Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI Patients
Mild Cognitive Impairment (MCI)
NCT07064005 Phase 1
Recruiting
Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.
Parkinsons Disease (PD)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology